Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas W. Martens & Christopher G. Parkin. (2022) How use of continuous glucose monitoring can address therapeutic inertia in primary care. Postgraduate Medicine 134:6, pages 576-588.
Read now
Read now
Jieling Chen, Magaly Perez-Nieves, Carolina Piras De Oliveira, Erik Spaepen, Beatrice Osumili, Jiat-Ling Poon, Nanette Schloot, Nuria Lara, Laura Garcia Alvarez & Montserrat Roset. (2020) An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany. Postgraduate Medicine 132:8, pages 727-736.
Read now
Read now
June M Tordoff, Charlotte Brenkley, Janet Krska & Alesha Smith. (2019) Exploring Medicines Burden Among Adults in New Zealand: A Cross-Sectional Survey. Patient Preference and Adherence 13, pages 2171-2184.
Read now
Read now
Mehdi Rezaei, Sina Valiee, Mohammad Tahan, Fariba Ebtekar & Reza Ghanei Gheshlagh. (2019) Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes, Metabolic Syndrome and Obesity 12, pages 589-599.
Read now
Read now
Carla Torre, José Guerreiro, Patrícia Longo, João Filipe Raposo, Hubert Leufkens & Ana Paula Martins. (2018) Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal. Patient Preference and Adherence 12, pages 1471-1482.
Read now
Read now
Articles from other publishers (33)
Paula M. Trief, Diane Uschner, Seth Kalichman, Barbara J. Anderson, Lida M. Fette, Hui Wen, Jane D. Bulger & Ruth S. Weinstock. (2023)
Psychosocial factors predict medication adherence in young adults with youth‐onset type 2 diabetes: Longitudinal results from the
TODAY2
i
Count
study
. Diabetic Medicine 40:5.
Crossref
Crossref
Tim Heise, Jenny Chien, John M. Beals, Charles Benson, Oliver Klein, Julie S. Moyers, Axel Haupt & Edward John Pratt. (2023) Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes. Diabetes, Obesity and Metabolism 25:4, pages 1080-1090.
Crossref
Crossref
Paula M. Trief, Seth Kalichman, Diane Uschner, Melinda Tung, Kimberly L. Drews, Barbara J. Anderson, Lida M. Fette, Hui Wen, Jane D. Bulger & Ruth S. Weinstock. (2022)
Association of psychosocial factors with medication adherence in emerging adults with
youth‐onset
type 2 diabetes: The
i
Count
study
. Pediatric Diabetes 23:8, pages 1695-1706.
Crossref
Crossref
Xiaowei Yan, Satish Mudiganti, Hannah Husby, Andrew Hudnut, Madina Gbotoe & J. B. Jones. (2022) Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases. Scientific Reports 12:1.
Crossref
Crossref
Yunita Linawati, Erna Kristin, Yayi Suryo Prabandari & Susi Ari Kristina. (2022) Exploring the Experiences and Needs of Patients With Type 2 Diabetes Mellitus in Sleman Regency, Yogyakarta, Indonesia: Protocol for a Qualitative Study. JMIR Research Protocols 11:9, pages e37528.
Crossref
Crossref
Tomoya Mita, Naoto Katakami, Mitsuyoshi Takahara, Masaru Kawashima, Fumitaka Wada, Hiroki Akiyama, Naru Morita, Yoko Kidani, Toshitaka Yajima, Iichiro Shimomura & Hirotaka Watada. (2022) Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment. The Journal of Clinical Endocrinology & Metabolism 107:9, pages 2424-2432.
Crossref
Crossref
Rick Siemens. (2022) Remote Pharmacist-Assisted Flash Continuous Glucose Monitoring Improves Glycemic Outcomes in Patients With Poorly Controlled Diabetes: A Retrospective Case Series. Clinical Diabetes 40:2, pages 211-221.
Crossref
Crossref
Marc Evans, Susanne Engberg, Mads Faurby, João Diogo Da Rocha Fernandes, Pollyanna Hudson & William Polonsky. (2021) Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes, Obesity and Metabolism 24:3, pages 377-390.
Crossref
Crossref
Paula M. Trief, Seth C. Kalichman, Dongliang Wang, Kimberly L. Drews, Barbara J. Anderson, Jane D. Bulger & Ruth S. Weinstock. (2022) Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study. Diabetes Research and Clinical Practice 184, pages 109216.
Crossref
Crossref
Julio Rosenstock & Stefano Del Prato. (2022) Basal weekly insulins: the way of the future!. Metabolism 126, pages 154924.
Crossref
Crossref
Serena Losi, Cesare Celeste Federico Berra, Riccardo Fornengo, Dario Pitocco, Giovanni Biricolti & Marco Orsini Federici. (2021) The role of patient preferences in adherence to treatment in chronic disease: a narrative review. Drug Target Insights 15, pages 13-20.
Crossref
Crossref
Grazia AleppoChristopher G. Parkin, Anders L. CarlsonRodolfo J. Galindo, Davida F. KrugerCarol J. LevyGuillermo E. UmpierrezGregory P. Forlenza & Janet B. McGill. (2021) Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. Diabetes Technology & Therapeutics 23:10, pages 715-725.
Crossref
Crossref
Erin R. Weeda, Alyssa K. Muraoka, Matthew D. Brock & Jessica M. Cannon. (2021) Medication adherence to injectable glucagon‐like peptide‐1 (GLP‐1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta‐analysis. International Journal of Clinical Practice 75:9.
Crossref
Crossref
Jerry R. FrankDeirdre BlissettRichard HellmundNaunihal Virdi. (2021) Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy. Diabetes Technology & Therapeutics 23:S3, pages S-36-S-44.
Crossref
Crossref
Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen, Melanie J. DaviesAmoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A. Senior, Robert J. Silver, Roberto Trevisan & Julio Rosenstock. (2021) Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial. Diabetes Care 44:7, pages 1586-1594.
Crossref
Crossref
Priti PednekarDebra A. HellerAndrew M. Peterson. (2020) Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program. Journal of Managed Care & Specialty Pharmacy 26:9, pages 1099-1108.
Crossref
Crossref
Yanru Qiao, Chi Chun Steve Tsang, Kenneth C. Hohmeier, Samantha Dougherty, Lisa Hines, Edward T. Chiyaka & Junling Wang. (2020) Association Between Medication Adherence and Healthcare Costs Among Patients Receiving the Low-Income Subsidy. Value in Health 23:9, pages 1210-1217.
Crossref
Crossref
Susan L. Karam, Jared Dendy, Shruti Polu & Lawrence Blonde. (2020) Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences. Diabetes Spectrum 33:1, pages 8-15.
Crossref
Crossref
César CaraballoJavier Valero-ElizondoRohan KheraShiwani MahajanGowtham R. GrandhiSalim S. ViraniReed MszarHarlan M. KrumholzKhurram Nasir. (2020) Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circulation: Cardiovascular Quality and Outcomes 13:2.
Crossref
Crossref
Eden Miller, Ankur Doshi, Randi Grøn, Esteban Jódar, Petra Őrsy, Mattis F. Ranthe, Danny Sugimoto, Nikolaos Tentolouris, Adie Viljoen & Liana K. Billings. (2019) IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy. Diabetes, Obesity and Metabolism 21:12, pages 2643-2650.
Crossref
Crossref
Troy Quast, Ross Andel & Archana R. Sadhu. (2019) Long-term Effects of Disasters on Seniors With Diabetes: Evidence From Hurricanes Katrina and Rita. Diabetes Care 42:11, pages 2090-2097.
Crossref
Crossref
Patrick J. Campbell. (2019) Adherence: An Important Metric to Assess Pharmacist Value in Quality Care. Journal of Managed Care & Specialty Pharmacy 25:10, pages 1044-1045.
Crossref
Crossref
Xizi Shen & Xingping Shen. (2019) The Role of Occupational Therapy in Secondary Prevention of Diabetes. International Journal of Endocrinology 2019, pages 1-7.
Crossref
Crossref
Yves Michiels, Olivier Bugnon, Annie Chicoye, Sylvie Dejager, Christine Moisan, François-André Allaert, Catherine Hunault, Laura Romengas, Hubert Méchin & Bruno Vergès. (2019) Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study. Advances in Therapy 36:6, pages 1291-1303.
Crossref
Crossref
Reema Mody, Qing Huang, Maria Yu, Ruizhi Zhao, Hiren Patel, Michael Grabner & Laura Fernández Landó. (2019) Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States. Diabetes, Obesity and Metabolism 21:4, pages 920-929.
Crossref
Crossref
Tom Quisel, Luca Foschini, Susan M Zbikowski & Jessie L Juusola. (2019) The Association Between Medication Adherence for Chronic Conditions and Digital Health Activity Tracking: Retrospective Analysis. Journal of Medical Internet Research 21:3, pages e11486.
Crossref
Crossref
Hiroe Nagaike, Makoto Ohara, Yo Kohata, Munenori Hiromura, Masako Tomoyasu, Michiya Takada, Takeshi Yamamoto, Toshiyuki Hayashi, Tomoyasu Fukui & Tsutomu Hirano. (2019) Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study. Diabetes Therapy 10:1, pages 215-228.
Crossref
Crossref
Manjiri D. Pawaskar, Liou Xu, Yuexin Tang, Gary A. Puckrein, Swapnil N. Rajpathak & Bruce Stuart. (2018) Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis. Diabetes Therapy 9:5, pages 1979-1993.
Crossref
Crossref
Steven V. Edelman & William H. Polonsky. (2017) Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 40:11, pages 1425-1432.
Crossref
Crossref
Lee-Kai Lin, Yan Sun, Bee Hoon Heng, Daniel Ek Kwang Chew & Phui-Nah Chong. (2017) Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Research & Care 5:1, pages e000429.
Crossref
Crossref
R Gale, P H Scanlon, M Evans, F Ghanchi, Y Yang, G Silvestri, M Freeman, A Maisey & J Napier. (2017) Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye 31:S1, pages S1-S20.
Crossref
Crossref
Lei Qin, Stephanie Chen, Emuella Flood, Alka Shaunik, Beverly Romero, Marie de la Cruz, Cynthia Alvarez & Susan Grandy. (2017) Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom. Diabetes Therapy 8:2, pages 335-353.
Crossref
Crossref
Lei Qin, Stephanie Chen, Emuella Flood, Alka Shaunik, Beverly Romero, Marie de la Cruz, Cynthia Alvarez & Susan Grandy. (2017) Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study. Diabetes Therapy 8:2, pages 321-334.
Crossref
Crossref